AIM share code: DVRG
18 January 2021
DeepVerge PLC
("DeepVerge" or "Company")
Exercise of Options
DeepVerge announces that it has received notification from UK EMI employee share option holders to exercise 25,860 shares in the issued share capital of DeepVerge ("the Option Shares"). The consideration for the exercise of the Option Shares at nominal value of 0.1p amounts, in aggregate, to a cash value of £25.86.
Application will be made for the Option Shares to be admitted to trading on AIM ("Admission"). Admission is expected to be on or about 22 January 2021.
Total voting rights
The Company's total issued capital, after the issue of the Option Shares, will be 169,540,071 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
Contacts
|
DeepVerge plc |
Gerard Brandon, CEO |
+44 (0) 7340 055 648 |
|
|
|
|
|
SPARK Advisory Partners Limited (Nominated Adviser) |
Neil Baldwin/Andrew Emmott |
+44 (0) 113 370 8974 |
|
|
|
|
|
Turner Pope Investments (TPI) Limited (Broker) |
Andy Thacker/Zoe Alexander |
+44 (0) 20 3657 0050 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.